[Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells

Yifei Xing1, Gongcheng Lu, Yajun Xiao

  • 1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Zhonghua Yi Xue Za Zhi
|January 3, 2003
PubMed
Abstract

Insights

The herpes simplex virus-thymidine kinase/ganciclovir (HSV-TK/GCV) suicide gene therapy

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Context:

  • Prostate cancer cell lines (PC-3m) exhibit reduced efficacy with HSV-TK/GCV therapy due to low connexin-mediated gap junctional intercellular communication (GJIC).
  • Connexin 43 (Cx43) expression is crucial for effective bystander effects in gene therapy.
  • Apigenin, a natural compound, is known to up-regulate connexin expression.

Purpose:

  • To evaluate the bystander effect of HSV-TK/GCV suicide gene therapy in PC-3m cells.
  • To investigate the role of GJIC and Cx43 in mediating the HSV-TK/GCV bystander effect.
  • To determine if apigenin can enhance the efficacy of HSV-TK/GCV therapy by modulating Cx43 expression and GJIC.

Summary:

  • The HSV-TK/GCV system demonstrated a limited bystander effect on PC-3m cells, correlated with low Cx43 expression and GJIC.
  • Apigenin treatment significantly increased Cx43 mRNA expression and GJIC in PC-3m cells, enhancing the HSV-TK/GCV bystander effect.
  • The combination of apigenin and HSV-TK/GCV therapy markedly improved cancer cell killing compared to GCV alone or with GJIC inhibitor (AGA).

Impact:

  • This study highlights the importance of GJIC in the efficacy of suicide gene therapy.
  • Apigenin shows potential as an adjuvant therapy to augment HSV-TK/GCV efficacy in prostate cancer.
  • Findings suggest strategies to improve gene therapy outcomes by targeting intercellular communication pathways.

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...